Glial Fibrillary Acid Protein Reflects Disease Activity in Autoimmune Encephalitis
European Journal of Neurology · 2025-05 · 32 (5)
DOI: 10.1111/ene.70207 ↗At a glance
Journal article in European Journal of Neurology, published online on 2025-05-23. Written by Johannes Piepgras and 7 co-authors. Institution: Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn2), University M…. Major MEDLINE topics: Glial Fibrillary Acidic Protein, Encephalitis, Neurofilament Proteins, Hashimoto Disease. Cited 9 times so far (Crossref); 24 references. The full text is freely available (open access, CC BY 4.0). Funded by: Else Kröner-Fresenius-Stiftung, Deutsche Forschungsgemeinschaft, Hermann und Lilly Schilling-Stiftung für Medizinische Forschung.
Abstract (original language)
Background and Purpose Management of autoimmune encephalitis (AE) is challenging due to a lack of reliable biomarkers. We here assess the combination of glial fibrillary acid protein (GFAP) and neurofilament (NfL) as biomarkers for diagnosis and disease monitoring of AE.
Methods
GFAP and NfL CSF levels (cGFAP, cNfL) of 42 AE patients were correlated with CSF markers of neuroinflammation. NfL/GFAP ratios were compared between patients with stable and active AE, stable and active multiple sclerosis (MS), and patients undergoing diagnostic lumbar puncture without evident pathological alterations (controls).
Results
In patients with AE, cGFAP levels showed strong correlations with albumin and IgG quotients and moderate correlations with CSF cell count; cNfL levels showed weak correlations with albumin quotients. cGFAP and cNfL levels showed no significant differences between patients with and without epileptic activity or inflammatory MRI lesions. Both sNfL and sGFAP correlated with the Clinical Assessment Scale in Autoimmune Encephalitis. Compared to NfL or GFAP alone, the NfL/GFAP ratio from CSF or serum led to a clearer separation of AE from MS patients and controls. Furthermore, serum NfL/GFAP ratios better discriminated active from stable AE. Conclusion cGFAP levels indicate intrathecal inflammatory processes in patients with active AE to a stronger degree than cNfL levels. Serum NfL/GFAP ratios recognize active AE, suggesting this ratio identifies AE patients with CNS‐compartmentalized neuronal injury (autoantibody‐mediated or cytotoxic) behind a relatively intact blood–brain barrier. Our findings indicate that the NfL/GFAP ratio can function as a blood‐based biomarker, aiding clinicians with diagnosis and disease management of AE.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germa…
- Mainz, Germany.
- Department of Pediatrics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
- Department of Neurology, Goethe University, University Hospital Frankfurt, Frankfurt am Main, Germany.
ORCID profiles: Marlene L Piepgras, Stefan Bittner
Funding
- Else Kröner-Fresenius-Stiftung
- Deutsche Forschungsgemeinschaft
- Hermann und Lilly Schilling-Stiftung für Medizinische Forschung
Cite
APA
Piepgras, J., Piepgras, M. L., Steffen, F., Ehrhardt, L., Schaller-Paule, M. A., Yalachkov, Y., Zipp, F., & Bittner, S. (2025). Glial Fibrillary Acid Protein Reflects Disease Activity in Autoimmune Encephalitis. European Journal of Neurology, 32(5). https://doi.org/10.1111/ene.70207
Vancouver
Piepgras J, Piepgras ML, Steffen F, Ehrhardt L, Schaller-Paule MA, Yalachkov Y, et al. Glial Fibrillary Acid Protein Reflects Disease Activity in Autoimmune Encephalitis. European Journal of Neurology. 2025;32(5). doi:10.1111/ene.70207
BibTeX
@article{Piepgras2025,
author = {Piepgras, Johannes and Piepgras, Marlene L and Steffen, Falk and Ehrhardt, Laura and Schaller-Paule, Martin A and Yalachkov, Yavor and Zipp, Frauke and Bittner, Stefan},
title = {Glial Fibrillary Acid Protein Reflects Disease Activity in Autoimmune Encephalitis},
journal = {European Journal of Neurology},
year = {2025},
volume = {32},
number = {5},
doi = {10.1111/ene.70207}
}
EUVIMED